4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-011319
President, R&D sold 80,450 shares at an average $4.50 ($362,298)
- President, R&D acquired 176,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bergstrom Donald A · President, R&D
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-28 | Sale : show line 1 in the form | −3,220 | $4.63 | $14,909 | 516,868 | D |
| 2025-01-28 | Grant or award : show line 2 in the form | +176,400 | 693,268 | D | ||
| 2025-01-29 | Sale : show line 3 in the form | −46,407 | $4.55 | $211,152 | 646,861 | D |
| 2025-01-30 | Sale : show line 4 in the form | −30,823 | $4.42 | $136,238 | 616,038 | D |
| Open-market sales · 80,450 sh · avg $4.50 · $362,298 | ||||||
Loading xslF345X05/ownership.xml…